Eight of the 63 applications to confess merchandise to Denmark’s medical cannabis trial scheme have received approval because the program’s inception in 2018, in response to a current disclosure by Health Minister Magnus Heunicke.

Heunicke offered the brand new figures in a solution to a parliamentary query from Member of Parliament Jane Heitmann.

Subsequently, nonetheless, 4 of the merchandise have been faraway from the approved listing as a result of they may not be offered within the country of origin, Canada.

Approval and regulatory compliance within the origin nation is a fundamental requirement for the admission of an imported cannabis product for the Danish scheme, Heunicke stated in his reply.

That only 12% of merchandise in the end reached the Danish market to date is an instance of the regulatory quagmire dealing with medical marijuana companies in some nations.

The lack of merchandise within the Danish market may also clarify, partially, why the Danish scheme has been in a tailspin because the center of final yr.

According to information from the Medicines Statistics Register, roughly 333 patients accessed Denmark’s medical cannabis scheme within the ultimate quarter of 2019.

That’s down from greater than 1,000 months earlier. (Read Full Article)

Source link